"That’s ridiculous and you are wrong the treasury is where our 700 million approx shares sit. It’s one in the same what do you think you burn them and they disappear, shares just don’t disappear, they are approved by shareholders as they were in the Nov 2017 annual meeting, there is no mechanism for them to disappear into thin air, they get returned to treasury where all the hundreds and hundreds of millions sit unused."

Just trying to get my mind around the potential. We have approx. 700M shares, worth hundreds of millions of dollars in the treasury. When and how does Generex access those funds for acquisitions, drug trials, etc.? In addition don't we have tens (hundreds?) of millions of dollars of losses on the books to offset earnings? Generex has "generated" income from sales of Excellagen, has strengthened it's cancer franchise with cutting edge technologies, has reinvigorated Oralyn with a two puff dosage and Altsulin, has purchased pharmacies, and is in the process of creating a full medical service MSO. I know I didn't mention all the assets, but is this a fairly accurate description of our investment?